Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.

Diagnostic and interventional radiology (Ankara, Turkey) - 1 Nov 2021

Yeniçeri İbrahim Önder, Yıldız Mehmet Erdem, Özduman Koray, Danyeli Ayça Erşen, Pamir M Necmettin, Dinçer Alp

Abstract excerpt

PURPOSE: The reliability and reproducibility of T2-weighted imaging/ fluid-attenuated inversion recovery (T2/FLAIR) mismatch were investigated in the diagnosis of isocitrate dehydrogenase (IDH) mutant astrocytoma between WHO grade II and III diffuse hemispheric gliomas. METHODS: WHO grade II and grade III diffuse hemispheric gliomas (n=133) treated in our institute were included in the study. Pathological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Imaging

Share to Mutation

Share to Reproducibility of Results

Source

Open in PubMed Open full text

Identifiers

PMID: 34792037
DOI: 10.5152/dir.2021.20624
PMCID: PMC8621633

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.PMID 34792037Read ↗

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas.Semantic proximity Read ↗

"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.Semantic proximity Read ↗

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.Semantic proximity Read ↗

Clinicopathological and radiological characteristics of false-positive and false-negative results in T2-FLAIR mismatch sign of IDH-mutated gliomas.Semantic proximity Read ↗

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.Semantic proximity Read ↗

T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.Semantic proximity Read ↗

T2-FLAIR mismatch in isocitrate dehydrogenase mutant astrocytomas: Variability and evolution.Semantic proximity Read ↗

T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant.Semantic proximity Read ↗

Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.Semantic proximity Read ↗

T2-FLAIR Mismatch Positive IDH-mutant Astrocytomas: Can We Identify High-grade Tumors Among them Before Surgery?Semantic proximity Read ↗

Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.Semantic proximity Read ↗

Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.